Related Experiment Video
Updated: May 9, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
New Systemic Inflammatory Indices as Predictors of Fulminant Myocarditis in Children
Demet Kangel1, İsa Ozyılmaz1, Sercin Ozkok2
1Division of Pediatric Cardiology, Department of Pediatrics, Basaksehir Cam and Sakura City Hospital, Istanbul 34480, Turkey.
Insights
New systemic inflammatory indices, Systemic Immune-Inflammation Index (SII) and Systemic Inflammatory Response Index (SIRI), can predict adverse outcomes in pediatric myocarditis. These simple blood markers offer early prognostic insights for children with myocarditis.
Area of Science:
- Pediatric Cardiology
- Inflammatory Diseases
- Biomarker Discovery
Background:
- Myocarditis is a significant cause of pediatric morbidity and mortality, potentially leading to severe long-term cardiac complications.
- New systemic inflammatory indices combining lymphocyte, neutrophil, and platelet counts show promise as prognostic markers.
Purpose of the Study:
- To investigate the utility of novel systemic inflammatory indices as early predictive markers for adverse outcomes in pediatric myocarditis.
- To compare these indices between fulminant and non-fulminant pediatric myocarditis cases.
Main Methods:
- Retrospective analysis of 122 pediatric myocarditis patients (age >1 month to <18 years) diagnosed between January 2022 and December 2024.
- Classification of patients into fulminant (requiring hemodynamic support) and non-fulminant groups.
- Calculation and comparison of Systemic Immune-Inflammation Index (SII) and Systemic Inflammatory Response Index (SIRI) values within the first 6 hours of diagnosis.
Main Results:
- The study included 122 pediatric myocarditis cases; 21.3% developed fulminant myocarditis.
- Median SII was significantly higher in the fulminant group (1300) compared to the non-fulminant group (500) (p < 0.05).
- Median SIRI was also significantly higher in the fulminant group (2.9) versus the non-fulminant group (1.5) (p < 0.05). Cut-off values for SII and SIRI were established for predicting fulminant myocarditis.
Conclusions:
- The Systemic Immune-Inflammation Index (SII) and Systemic Inflammatory Response Index (SIRI) show potential as independent predictors of adverse myocarditis prognosis in children.
- These indices are easily calculable from routine blood tests, offering a practical approach for early risk stratification in pediatric myocarditis.
Abstract:
Background/Objectives: Myocarditis is a major cause of morbidity and mortality in children and can lead to long-term heart failure, dilated cardiomyopathy, the need for heart transplantation, or death. New systemic inflammatory indices that combine lymphocyte, neutrophil, and platelet counts have been recently used as strong prognostic markers of some inflammatory diseases and adverse outcomes of neoplasms. This study aimed to investigate the use of new systemic indices as early predictive markers for adverse outcomes in patients with pediatric myocarditis. Methods: This study retrospectively examined patients between the ages of >1 month and <18 years who were monitored in our clinic with a diagnosis of myocarditis between 1 January 2022 and 31 December 2024. The cases were divided into two groups: fulminant myocarditis (requiring the use of inotropes or extracorporeal membrane oxygenation due to hemodynamic disturbance) and non-fulminant myocarditis. The systemic inflammatory index values of these groups (calculated in the first 6 h) were compared, and the results were statistically analyzed. Results: The study included 122 pediatric myocarditis cases treated during the study period (80 boys; median age: 11 (IQR: 8-14) years). Twenty-six of these patients (21.3%) developed fulminant myocarditis. The median systemic immune-inflammation index (SII) value in the group with fulminant myocarditis was 1300 (IQR: 1000-1600), while this value was 500 (IQR: 350-650) for the non-fulminant group (p < 0.05). The median systemic inflammatory response index (SIRI) values were 2.9 (IQR: 2.5-3.2) in the fulminant myocarditis group and 1.5 (IQR: 1.2-1.8) in the non-fulminant group (p < 0.05). The cut-off values for fulminant myocarditis were found to be 1050 for the SII, with an AUC value of 0.76 (95% confidence interval: 0.80-0.96; p < 0.001), and 1.9 for the SIRI, with an AUC value of 0.64. Conclusions: The SII and SIRI may independently predict adverse myocarditis prognoses in children. These new biomarkers are easy to calculate using routine blood parameters.
More Related Videos
06:49Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy
Published on: May 31, 2017
08:41Assessment of Cardiac Function and Myocardial Morphology Using Small Animal Look-locker Inversion Recovery SALLI MRI in Rats
Published on: July 19, 2013
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...